Literature DB >> 11089719

Early detection and aggressive treatment of prostate cancer: groping in the dark.

M J Barry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11089719      PMCID： PMC1495598          DOI： 10.1046/j.1525-1497.2000.00816.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  17 in total

1.  Extended field prostate biopsies: too much of a good thing?

Authors:  M K Terris
Journal:  Urology       Date:  2000-04       Impact factor: 2.649

2.  Extended field prostate biopsy enhances cancer detection.

Authors:  R J Babaian
Journal:  Urology       Date:  2000-04       Impact factor: 2.649

3.  A PSA threshold of 4.0 ng/mL for early detection of prostate cancer: the only rational approach for men 50 years old and older.

Authors:  H B Carter
Journal:  Urology       Date:  2000-06       Impact factor: 2.649

4.  Lowering PSA cutoffs to enhance detection of curable prostate cancer.

Authors:  W J Catalona; C G Ramos; G F Carvalhal; Y Yan
Journal:  Urology       Date:  2000-06       Impact factor: 2.649

5.  Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates.

Authors:  R E Tarone; K C Chu; O W Brawley
Journal:  Epidemiology       Date:  2000-03       Impact factor: 4.822

6.  Prostate cancer detection at low prostate specific antigen.

Authors:  F H Schröder; I van der Cruijsen-Koeter; H J de Koning; A N Vis; R F Hoedemaeker; R Kranse
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

7.  Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.

Authors:  B Djavan; A Zlotta; M Remzi; K Ghawidel; A Basharkhah; C C Schulman; M Marberger
Journal:  J Urol       Date:  2000-04       Impact factor: 7.450

8.  Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality.

Authors:  R Etzioni; J M Legler; E J Feuer; R M Merrill; K A Cronin; B F Hankey
Journal:  J Natl Cancer Inst       Date:  1999-06-16       Impact factor: 13.506

9.  Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.

Authors:  F J Fowler; M McNaughton Collins; P C Albertsen; A Zietman; D B Elliott; M J Barry
Journal:  JAMA       Date:  2000-06-28       Impact factor: 56.272

10.  Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993).

Authors:  F J Fowler; M J Barry; G Lu-Yao; A Roman; J Wasson; J E Wennberg
Journal:  Urology       Date:  1993-12       Impact factor: 2.649
View more
  2 in total

Review 1.  Prostate-specific antigen in the early detection of prostate cancer.

Authors:  Ian M Thompson; Donna P Ankerst
Journal:  CMAJ       Date:  2007-06-19       Impact factor: 8.262

2.  The knowledge and attitude towards prostate cancer and screening practices among males in Saudi Arabia.

Authors:  Abdulrahman Musaad Alothman; Alhanouf Fahad Altamimi; Alanoud Waleed Alhenaki; Nouf Mohammed Almansour; Abdulrhman Khalid Alhusaini; Fahad Alateeq
Journal:  J Family Med Prim Care       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.